DS3790

N/A

Report date: 2025/12/01 11:40:08

Base Information

Drug NameDS3790

Drug Alias NameDS3790DS-3790

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionLeukocyte antigen CD37 antagonists

TargetsLeukocyte antigen CD37

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesDaiichi Sankyo Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A